Transcriptional suppression of CD8+ T cell exhaustion for improving T cell immunotherapy

Código QR

Transcriptional suppression of CD8+ T cell exhaustion for improving T cell immunotherapy

Guardado en:

Detalles Bibliográficos
Autores principales:	Xue Yang, Bingjing Wang, Xuetao Cao
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/b8cf7f41d0be4e0090d84157c9577c71
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity
por: Rosmely Hernandez, et al.
Publicado: (2021)

Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design
por: Haiying Qin, et al.
Publicado: (2021)

Estrogen receptor beta signaling in CD8+ T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch
por: Jing Yang, et al.
Publicado: (2021)

Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy
por: Ruining Gong, et al.
Publicado: (2021)

CCT8 recovers WTp53-suppressed cell cycle evolution and EMT to promote colorectal cancer progression
por: Qing Liao, et al.
Publicado: (2021)

Correction: Estrogen receptor beta signaling in CD8+ T cells boosts T cell receptor activation and antitumor immunity through a phosphotyrosine switch
Publicado: (2021)

Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma
por: Thomas F Gajewski, et al.
Publicado: (2021)

Correction: Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma
Publicado: (2021)

CXCR6 by increasing retention of memory CD8+ T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer
por: Wenjun He, et al.
Publicado: (2021)

Novel potent anti-STEAP1 bispecific antibody to redirect T cells for cancer immunotherapy
por: Hong-fen Guo, et al.
Publicado: (2021)

Advances in Biomarkers for Immunotherapy of Non-small Cell Lung Cancer
por: Chuan HUANG, et al.
Publicado: (2021)

Cancer immunology and immunotherapy
por: Xiubao Ren
Publicado: (2021)

Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy.
por: Vincenzo Mazzaferro, et al.
Publicado: (2021)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma
por: Amaia Lujambio, et al.
Publicado: (2021)

Primary vulvar squamous cell carcinomas with high T cell infiltration and active immune signaling are potential candidates for neoadjuvant PD-1/PD-L1 immunotherapy
por: Sjoerd H van der Burg, et al.
Publicado: (2021)

Correction: THADA drives Golgi residency and upregulation of PD-L1 in cancer cells and provides promising target for immunotherapy
Publicado: (2021)

Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment
por: Yuqi Wang, et al.
Publicado: (2021)

Overexpression of CD200 is a stem cell-specific mechanism of immune evasion in AML
por: R Eric Davis, et al.
Publicado: (2021)

GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma
por: Meng Li, et al.
Publicado: (2021)

Bispecific antibody targeting TROP2xCD3 suppresses tumor growth of triple negative breast cancer
por: Huicheng Liu, et al.
Publicado: (2021)

Real-world performance of blood-based proteomic profiling in first-line immunotherapy treatment in advanced stage non-small cell lung cancer
por: Wallace Akerley, et al.
Publicado: (2021)

CD8+ TILs in NSCLC differentiate into TEMRA via a bifurcated trajectory: deciphering immunogenicity of tumor antigens
por: Sung-Woo Lee, et al.
Publicado: (2021)

Novel emerging biomarkers to immunotherapy in kidney cancer
por: Yasser Ged, et al.
Publicado: (2021)

Immunotherapy in breast cancer: A clinician's perspective
por: Sibapriya Chaudhuri, et al.
Publicado: (2021)

Leveraging the Treg-intrinsic CTLA4–PKCη signaling pathway for cancer immunotherapy
por: Hsin-Yu Liu, et al.
Publicado: (2021)

Cancer-specific type-I interferon receptor signaling promotes cancer stemness and effector CD8+ T-cell exhaustion
por: Wang Gong, et al.
Publicado: (2021)

Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis
por: Sandra Parenti, et al.
Publicado: (2021)

Dramatic response of metaplastic breast cancer to chemo-immunotherapy
por: Sylvia Adams
Publicado: (2017)

Simple and effective bacterial-based intratumoral cancer immunotherapy
por: Teresa Neeman, et al.
Publicado: (2021)

DNA methylation-based signature of CD8+ tumor-infiltrating lymphocytes enables evaluation of immune response and prognosis in colorectal cancer
por: Rish K Pai, et al.
Publicado: (2021)

MiR-186 Suppressed Growth, Migration, and Invasion of Lung Adenocarcinoma Cells via Targeting Dicer1
por: Juan Wang, et al.
Publicado: (2021)

Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients
por: Yves Boucher, et al.
Publicado: (2021)

lncRNA RP11-147L13.8 suppresses metastasis and chemo-resistance by modulating the phosphorylation of c-Jun protein in GBC
por: Bohao Zheng, et al.
Publicado: (2021)

Correction: CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells
Publicado: (2021)

The role of DLL1 in long-term vascular normalization and cancer immunotherapy
por: Qiaozhen Wu, et al.
Publicado: (2021)

Sporoderm-Removed Spore Powder May Suppress the Proliferation, Migration, and Invasion of Esophageal Squamous Cell Carcinoma Cells Through PI3K/AKT/mTOR and Erk Pathway
por: Guiping Liu Master degree, et al.
Publicado: (2021)

MiR-101-3p Suppresses Progression of Cervical Squamous Cell Carcinoma by Targeting and Down-Regulating KPNA2
por: Hong Wang MM, et al.
Publicado: (2021)

Pan-cancer analysis of SETD2 mutation and its association with the efficacy of immunotherapy
por: Mingdong Lu, et al.
Publicado: (2021)

Loss of MBD2 attenuates MLL-AF9-driven leukemogenesis by suppressing the leukemic cell cycle via CDKN1C
por: Kuangguo Zhou, et al.
Publicado: (2021)

PD-1 blockade improves the anti-tumor potency of exhausted CD3+CD56+ NKT-like cells in patients with primary hepatocellular carcinoma
por: Longxiang Tao, et al.
Publicado: (2021)